StockData
PROCEPT BioRobotics Corp logo

PROCEPT BioRobotics Corp (PRCT) stock

PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3049% below fair value
$23.78+0.24 (+1.02%)

Close on Nov 17, 2026Market cap $1.36BP/E –Yield –

PROCEPT BioRobotics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

PROCEPT BioRobotics's operating income for the twelve months ending Jun 30, 2026 was -$114.23M. For fiscal 2025 it was -$103.86M. The highest annual figure on record is -$47.80M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$103.86M–
FY2024Dec 31, 2024-$96.61M–
FY2023Dec 31, 2023-$109.17M–
FY2022Dec 31, 2022-$80.72M–
FY2021Dec 31, 2021-$54.16M–
FY2020Dec 31, 2020-$47.80M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$27.39M–
Q1 FY2026Mar 31, 2026-$32.61M–
Q4 FY2025Dec 31, 2025-$31.04M–
Q3 FY2025Sep 30, 2025-$23.19M–
Q2 FY2025Jun 30, 2025-$22.19M–
Q1 FY2025Mar 31, 2025-$27.44M–
Q4 FY2024Dec 31, 2024-$19.71M–
Q3 FY2024Sep 30, 2024-$22.43M–
Q2 FY2024Jun 30, 2024-$26.83M–
Q1 FY2024Mar 31, 2024-$27.65M–
Q4 FY2023Dec 31, 2023-$29.56M–
Q3 FY2023Sep 30, 2023-$25.61M–
Q2 FY2023Jun 30, 2023-$25.63M–
Q1 FY2023Mar 31, 2023-$28.38M–
Q4 FY2022Dec 31, 2022-$25.04M–
Q3 FY2022Sep 30, 2022-$22.11M–
Q2 FY2022Jun 30, 2022-$17.88M–
Q1 FY2022Mar 31, 2022-$15.70M–
Q4 FY2021Dec 31, 2021-$16.83M–
Q3 FY2021Sep 30, 2021-$12.80M–
Q2 FY2021Jun 30, 2021-$13.19M–
Q1 FY2021Mar 31, 2021-$11.34M–
Q4 FY2020Dec 31, 2020-$13.21M–
Q3 FY2020Sep 30, 2020-$10.98M–

More PROCEPT BioRobotics figures

See a number that looks wrong?